Delivery of A Chemically Modified Noncoding RNA Domain Improves Dystrophic Myotube Function
Advanced Science · 2025
DOI: 10.1002/advs.202410908 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Zeinabou Niasse-Sy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Integrative Systems Physiology, École polytechnique fédérale de Lausanne (EPFL), Lausanne, 1015, Switzerland. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Muscle Fibers, Skeletal, RNA, Long Noncoding. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondation Suisse de Recherche sur les Maladies Musculaires (FSRMM), European Research Council.
Abstract (Originalsprache)
Fast twitch muscle fibers are prone to degradation in skeletal muscle pathologies, such as sarcopenia and muscular dystrophies. We previously showed that the exercise‐induced long noncoding RNA CYTOR promotes fast‐twitch myogenesis. Here, we identify an independent functional element within human CYTOR, and optimize its RNA delivery. In human primary myoblasts exogenous CYTOR exon 2 recapitulates the effect of full‐length CYTOR by boosting fast‐twitch myogenic differentiation. Furthermore, chemically modified CYTOR exon 2 RNA ΨU (N1‐me‐PseudoU, 7‐methyl guanosine 5′Cap, polyA) enhances RNA stability and reduces immunogenicity to CYTOR exon2 RNA. Viral‐ or chemically optimized RNA‐mediated CYTOR exon2 administration drives commitment toward myogenic maturation in Duchenne muscular dystrophy‐derived primary myoblasts, myogenic progenitor cells, and mouse embryonic stem cells. Furthermore, CYTOR exon2, m1ΨU improves key disease characteristics in dystrophic myotubes, including calcium handling and mitochondrial bioenergetics. In summary, we identify CYTOR exon 2 as the functional domain of CYTOR that can be delivered in a disease context using chemical modifications. This is of particular importance given the susceptibility of fast muscle fibers in different muscle pathologies such as aging and dystrophies, and the oncogenic effect of CYTOR exon 1. This study, therefore, highlights the potential of identifying functional domains in noncoding RNAs. Delivery, or targeting of RNA domains might constitute next‐generation RNA therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Integrative Systems Physiology, École polytechnique fédérale de Lausanne (EPFL), Lausanne, 1015, Switzerland.
- Université Lyon, Faculté de Médecine et de Maïeutique Lyon-Sud Charles Merieux, Oullins, 69007, France.
- Hospices Civils de Lyon, Groupement Hospitalier Sud, Service de Gériatrie, Lyon, 69002, France.
- Massachusetts Institute of Technology (MIT), Cambridge, 02139, USA.
- Laboratory of Regenerative and Muscle Biology, Institute of Human Movement Sciences and Sport, Department of Health Sciences and Technology, ETH Zurich, Schwerzenbach, 8603, Switzerland.
ORCID-Profile: Martin Wohlwend
Förderung
- Fondation Suisse de Recherche sur les Maladies Musculaires (FSRMM)
- European Research Council
Zitieren
APA
Niasse-Sy, Z., Zhao, B., Lenardič, A., Luong, H. T. T., Bar-Nur, O., Auwerx, J., & Wohlwend, M. (2025). Delivery of A Chemically Modified Noncoding RNA Domain Improves Dystrophic Myotube Function. Advanced Science. https://doi.org/10.1002/advs.202410908
Vancouver
Niasse-Sy Z, Zhao B, Lenardič A, Luong HTT, Bar-Nur O, Auwerx J, et al. Delivery of A Chemically Modified Noncoding RNA Domain Improves Dystrophic Myotube Function. Advanced Science. 2025. doi:10.1002/advs.202410908
BibTeX
@article{NiasseSy2025,
author = {Niasse-Sy, Zeinabou and Zhao, Bo and Lenardič, Ajda and Luong, Huyen Thuc Tran and Bar-Nur, Ori and Auwerx, Johan and Wohlwend, Martin},
title = {Delivery of A Chemically Modified Noncoding RNA Domain Improves Dystrophic Myotube Function},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202410908}
}
EUVIMED